Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FERINJECT versus Venofer for iron deficiency anemia in inflammatory bowel disease
2008-002333-75Phase 3Completed
- Sponsor
- CSL Vifor
- Start
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in iron deficiency anemia (IDA) and inflammatory bowel disease (IBD) comparing FERINJECT standardized dosing regimen with Venofer individually calculated dosing regimen (2 arms). Started Aug 2008; status: completed.
02
Drugs
ferric carboxymaltoseiron sucrose
03
Conditions
iron deficiency anemia (IDA)inflammatory bowel disease (IBD)
Beyond the preview
Go deeper on 2008-002333-75.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002333-75.